Neuca

Neuca Years Dividend Increased

The Years of Consecutive Dividend Increases of Neuca (NEU.WA) as of Oct 21, 2026 is 19. In the previous year, Years of Consecutive Dividend Increases was 19.00 — a change of 0.00% (lower).

Years Dividend Increased

19

YoY

0.00%

Last updated:

Years of Consecutive Dividend Increases of Neuca is 2025 19 . Years of Consecutive Dividend Increases of Neuca was 2024 19.00 . It decreases by 0.00% lower compared to the previous year.

The Neuca Years Dividend Increased history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Years Dividend Increased
Date
Years Dividend Increased
Jan 1, 2018
19.00 PLN
Jan 1, 2019
19.00 PLN
Jan 1, 2020
19.00 PLN
Jan 1, 2021
19.00 PLN
Jan 1, 2022
19.00 PLN
Jan 1, 2023
19.00 PLN
Jan 1, 2024
19.00 PLN
Jan 1, 2025
19.00 PLN
The Neuca Years Dividend Increased history
YEARYears Dividend IncreasedYoY
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
190.00%
19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Years of Consecutive Dividend Increases of Neuca is 19 in 2025.

Years of Consecutive Dividend Increases of Neuca changed from 19.00 to 19, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Years of Consecutive Dividend Increases Neuca since 2006 – with annual values, charts, and detailed analysis.

This measures how many consecutive years the dividend has been raised. Companies with 25+ years are considered Dividend Aristocrats.

Years of Consecutive Dividend Increases's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Years of Consecutive Dividend Increases's Neuca historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Neuca

All Key Metrics — Neuca